Literature DB >> 2981701

Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase.

S Ronca-Testoni, S Hrelia, G Hakim, C A Rossi.   

Abstract

Some smooth muscle relaxant drugs with an unknown mechanism of action have been tested for their interaction with calmodulin and with calmodulin-induced cyclic nucleotide phosphodiesterase (PDE) activity. The affinity of these drugs for calmodulin does not parallel their inhibitory effect on the calmodulin activation of PDE. The lack of parallelism could be due to a binding of the drugs to different sites on calmodulin; furthermore a binding of papaverine, octylonium bromide and felodipine to PDE molecule might also be considered to explain their inhibitory effect on PDE basal activity. The myolytic effect of octylonium bromide and pinaverium bromide may be due to their interaction with calmodulin-dependent systems.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981701     DOI: 10.1007/bf02005883

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  15 in total

1.  Calcium-dependent affinity chromatography of calmodulin on an immobilized phenothiazine.

Authors:  G A Jamieson; T C Vanaman
Journal:  Biochem Biophys Res Commun       Date:  1979-10-12       Impact factor: 3.575

2.  Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.

Authors:  B Weiss; R M Levin
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

3.  Effect of calcium(II) on the interaction between the subunits of troponin and tropomyosin.

Authors:  J P Van Eerd; Y Kawasaki
Journal:  Biochemistry       Date:  1973-11-20       Impact factor: 3.162

4.  Local anesthetics, mepacrine, and propranolol are antagonists of calmodulin.

Authors:  M Volpi; R I Sha'afi; P M Epstein; D M Andrenyak; M B Feinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships.

Authors:  W C Prozialeck; B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1982-09       Impact factor: 4.030

6.  Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I.

Authors:  R L Kincaid; M Vaughan; J C Osborne; V A Tkachuk
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

7.  Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase.

Authors:  H Hidaka; T Yamaki; M Naka; T Tanaka; H Hayashi; R Kobayashi
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

8.  Hydrophobic regions function in calmodulin-enzyme(s) interactions.

Authors:  T Tanaka; H Hidaka
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

9.  Calcium-induced exposure of a hydrophobic surface on calmodulin.

Authors:  D C LaPorte; B M Wierman; D R Storm
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

10.  Allosteric interactions among drug binding sites on calmodulin.

Authors:  J D Johnson
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

View more
  1 in total

1.  Effects of pinaverium on voltage-activated calcium channel currents of single smooth muscle cells isolated from the longitudinal muscle of the rabbit jejunum.

Authors:  D J Beech; I MacKenzie; T B Bolton; M O Christen
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.